Display Settings:

Items per page

Results: 8

1.
2.
Figure 1

Figure 1. From: In Vitro and In Vivo Evaluation of Polyherbal Formulation against Russell's Viper and Cobra Venom and Screening of Bioactive Components by Docking Studies.

Structure of (a) leucasin isolated from LA, (b) aristolochic acids from AB.

G. Sakthivel, et al. Evid Based Complement Alternat Med. 2013;2013:781216.
3.
Figure 4

Figure 4. From: In Vitro and In Vivo Evaluation of Polyherbal Formulation against Russell's Viper and Cobra Venom and Screening of Bioactive Components by Docking Studies.

Protein structure is shown in wireframe model. Metapockets are shown in transparent solid surface form.

G. Sakthivel, et al. Evid Based Complement Alternat Med. 2013;2013:781216.
4.
Figure 2

Figure 2. From: In Vitro and In Vivo Evaluation of Polyherbal Formulation against Russell's Viper and Cobra Venom and Screening of Bioactive Components by Docking Studies.

Histogram showing effect of Rutin (RU), Aristolochia bracteolate (AB), Leucas aspera (LA), and Tylophora-indica (TI) on DPPH* radicals (B), Reducing Power (C), and Superoxide scavenging activity (D) in vitro.

G. Sakthivel, et al. Evid Based Complement Alternat Med. 2013;2013:781216.
5.
Figure 6

Figure 6. From: In Vitro and In Vivo Evaluation of Polyherbal Formulation against Russell's Viper and Cobra Venom and Screening of Bioactive Components by Docking Studies.

Leucasin-PLA2 binding predicted using DS package v2.5. Protein residues (blue color) and ligand (green color) are represented by thin and sticks, respectively. Ligand binding regions are represented as ball and stick model. Hydrogen bonds are shown in blue dashed solid lines, respectively.

G. Sakthivel, et al. Evid Based Complement Alternat Med. 2013;2013:781216.
6.
Figure 8

Figure 8. From: In Vitro and In Vivo Evaluation of Polyherbal Formulation against Russell's Viper and Cobra Venom and Screening of Bioactive Components by Docking Studies.

Glide v4.5 representation of Leucasin-PLA2 interaction. Protein residues (blue color) and ligand (green color) are represented by thin and sticks, respectively. Ligand binding regions are represented as ball and stick model. Hydrogen bonds are shown in blue dashed solid lines, respectively.

G. Sakthivel, et al. Evid Based Complement Alternat Med. 2013;2013:781216.
7.
Figure 5

Figure 5. From: In Vitro and In Vivo Evaluation of Polyherbal Formulation against Russell's Viper and Cobra Venom and Screening of Bioactive Components by Docking Studies.

Aristolochic acids-PLA2 binding predicted using DS package v2.5. Protein residues (blue color) and ligand (green color) are represented by thin and sticks, respectively. Ligand binding regions are represented as ball and stick model. Hydrogen bonds are shown in blue dashed solid lines, respectively.

G. Sakthivel, et al. Evid Based Complement Alternat Med. 2013;2013:781216.
8.
Figure 7

Figure 7. From: In Vitro and In Vivo Evaluation of Polyherbal Formulation against Russell's Viper and Cobra Venom and Screening of Bioactive Components by Docking Studies.

Glide v4.5 representation of Aristolochic Acids-PLA2 interaction. Protein residues (blue color) and ligand (green color) are represented by thin and sticks, respectively. Ligand binding regions are represented as ball and stick model. Hydrogen bonds are shown in blue dashed solid lines, respectively.

G. Sakthivel, et al. Evid Based Complement Alternat Med. 2013;2013:781216.

Display Settings:

Items per page

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk